Advisor Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $4.81M | Buy |
9,965
+321
| +3% | +$159K | 0.34% | 55 |
|
|
2022
Q1 | $4.74M | Buy |
9,644
+661
| +7% | +$302K | 0.3% | 61 |
|
|
2021
Q4 | $4.16M | Buy |
8,983
+286
| +3% | +$120K | 0.25% | 72 |
|
|
2021
Q3 | $3.24M | Sell |
8,697
-176
| -2% | -$66.9K | 0.22% | 86 |
|
|
2021
Q2 | $3.39M | Sell |
8,873
-39
| -0.4% | -$14.9K | 0.22% | 83 |
|
|
2021
Q1 | $3.2M | Sell |
8,912
-683
| -7% | -$220K | 0.23% | 81 |
|
|
2020
Q4 | $3.08M | Buy |
9,595
+294
| +3% | +$90.2K | 0.23% | 80 |
|
|
2020
Q3 | $2.5M | Sell |
9,301
-122
| -1% | -$32.8K | 0.21% | 85 |
|
|
2020
Q2 | $2.48M | Buy |
9,423
+712
| +8% | +$190K | 0.23% | 83 |
|
|
2020
Q1 | $1.98M | Buy |
8,711
+361
| +4% | +$98.4K | 0.24% | 89 |
|
|
2019
Q4 | $2.52M | Buy |
8,350
+156
| +2% | +$42.9K | 0.26% | 78 |
|
|
2019
Q3 | $1.97M | Buy |
8,194
+186
| +2% | +$51K | 0.24% | 81 |
|
|
2019
Q2 | $2.26M | Sell |
8,008
-365
| -4% | -$99.7K | 0.28% | 71 |
|
|
2019
Q1 | $2.4M | Sell |
8,373
-246
| -3% | -$71.1K | 0.31% | 65 |
|
|
2018
Q4 | $2.26M | Buy |
8,619
+972
| +13% | +$267K | 0.36% | 60 |
|
|
2018
Q3 | $2.1M | Buy |
7,647
+38
| +0.5% | +$9.87K | 0.28% | 69 |
|
|
2018
Q2 | $1.81M | Buy |
7,609
+247
| +3% | +$57.2K | 0.31% | 68 |
|
|
2018
Q1 | $1.62M | Buy |
7,362
+31
| +0.4% | +$7.28K | 0.3% | 71 |
|
|
2017
Q4 | $1.83M | Buy |
7,331
+144
| +2% | +$30.7K | 0.33% | 64 |
|
|
2017
Q3 | $1.36M | Sell |
7,187
-145
| -2% | -$27.6K | 0.27% | 77 |
|
|
2017
Q2 | $1.38M | Buy |
7,332
+198
| +3% | +$35.6K | 0.32% | 73 |
|
|
2017
Q1 | $1.18M | Buy |
7,134
+1,072
| +18% | +$171K | 0.31% | 76 |
|
|
2016
Q4 | $872K | Buy |
6,062
+685
| +13% | +$91.7K | 0.26% | 97 |
|
|
2016
Q3 | $674K | Sell |
5,377
-737
| -12% | -$95.2K | 0.22% | 113 |
|
|
2016
Q2 | $803K | Buy |
6,114
+189
| +3% | +$25.9K | 0.28% | 94 |
|
|
2016
Q1 | $824K | Sell |
5,925
-908
| -13% | -$121K | 0.31% | 92 |
|
|
2015
Q4 | $953K | Buy |
6,833
+89
| +1% | +$12.3K | 0.33% | 89 |
|
|
2015
Q3 | $944K | Sell |
6,744
-409
| -6% | -$61.5K | 0.4% | 71 |
|
|
2015
Q2 | $1.12M | Buy |
7,153
+554
| +8% | +$88.5K | 0.43% | 68 |
|
|
2015
Q1 | $1.02M | Buy |
6,599
+1,200
| +22% | +$171K | 0.43% | 63 |
|
|
2014
Q4 | $678K | Buy |
+5,399
| New | +$667K | 0.3% | 103 |
|
|
2014
Q3 | – | Sell |
-6,773
| Closed | -$729K | – | 247 |
|
|
2014
Q2 | $729K | Buy |
6,773
+335
| +5% | +$34.5K | 0.36% | 87 |
|
|
2014
Q1 | $641K | Buy |
6,438
+144
| +2% | +$13K | 0.35% | 87 |
|
|
2013
Q4 | $581K | Buy |
6,294
+214
| +4% | +$19K | 0.33% | 94 |
|
|
2013
Q3 | $508K | Buy |
6,080
+218
| +4% | +$18.7K | 0.36% | 92 |
|
|
2013
Q2 | $480K | Buy |
+5,862
| New | +$439K | 0.39% | 88 |
|
Other funds holding ELV
Advisor Partners's ELV Position: Q2 2022 in Review
Advisor Partners increased its Elevance Health (ELV) stake by 3.3% in Q2 2022, buying an estimated $159K and bringing the position to 9,965 shares worth $4.81M. The position accounts for 0.34% of the portfolio, ranked #55.
Advisor Partners first reported a position in ELV in Q2 2013 and has held it in 36 quarters since. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.
- Advisor Partners held 9,965 shares of Elevance Health worth $4.81M as of Q2 2022.
- Advisor Partners bought 321 Elevance Health shares in Q2 2022, an estimated $159K.
- Elevance Health made up 0.34% of Advisor Partners's portfolio in Q2 2022, its #55 holding.
- Advisor Partners first reported a position in Elevance Health in Q2 2013 and has held it in 36 quarters since.
- 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.
Based on Advisor Partners's 13F filing for Q2 2022, filed 11 Aug 2022.